Grants per year
Personal profile
Research Interests
The Division of Immunotherapy and Autoimmune Diseases (DIAD) is the only center in the world devoted to a unique area of treatment and research utilizing stem cell transplantation in clinical trials for autoimmune diseases and vascular diseases. DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat: Multiple Sclerosis (MS), Diabetes, Lupus, Crohn’s, Rheumatoid Arthritis, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Phemphigus, Dermatomyositis, Devic’s, Myasthenia Gravis, Polymositis and Scleroderma
Certifications and Licenses
| Internal Medicine | |
| Hematology/Oncology |
Training Experience
| 1987 | Residency, Baylor Affiliated Hospitals |
| 1993 | Fellowship, National Institutes of Health |
Education/Academic qualification
MD, Saint Louis University
… → 1984
Research interests
- Autoimmune Diseases
- Vascular Biology
Fingerprint
Dive into the research topics where Richard K Burt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 14 Finished
-
Stem Cell Transplantation for Autoimmune Diseases
Northwestern Memorial Hospital, Illinois Department of Healthcare and Family Services
9/1/12 → 8/31/15
Project: Research project
-
Hematopoietic Stem Cell Transplantation for Autoimmune Hepatitis
Masimo Foundation for Ethics, Innovation, and Competition in Healthcare
1/1/12 → 12/31/12
Project: Research project
-
Peptide Vaccine Suppressing Autoantigen-Specific Response in Human Lupus
Burt, R. K., Datta, S. K. & Zhang, L.
4/1/11 → 9/30/14
Project: Research project
-
Hematopoietic Stem Cell Transplantation Induces Remission in Lupus
Lupus Foundation of America, Inc.
2/1/10 → 9/30/12
Project: Research project
Research Output
-
Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days
Burt, R. K., Han, X., Quigley, K., Arnautovic, I., Shah, S. J., Lee, D. C., Freed, B. H., Jovanovic, B. & Helenowski, I. B., Jan 2021, In: Bone Marrow Transplantation. 56, 1, p. 50-59 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease
Burt, R. K., Craig, R., Yun, L., Halverson, A., Quigley, K., Arnautovic, I. & Han, X., Dec 2020, In: Bone Marrow Transplantation. 55, 12, p. 2343-2346 4 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America
Burt, R. K., Tappenden, P., Han, X., Quigley, K., Arnautovic, I., Sharrack, B., Snowden, J. A. & Hartung, D., Oct 2020, In: Multiple Sclerosis and Related Disorders. 45, 102404.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy
Burt, R. K., Balabanov, R., Tavee, J., Han, X., Sufit, R., Ajroud-Driss, S., Jovanovic, B., Quigley, K., Arnautovic, I., Helenowski, I. & Sharrack, B., Nov 1 2020, In: Journal of Neurology. 267, 11, p. 3378-3391 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In: Neurology. 93, 18, p. E1732-E1741Research output: Contribution to journal › Article › peer-review
13 Scopus citations